Home > Insider Trading > Filing (0001209191-15-079483)

Filing Details

Accession Number:: 0001209191-15-079483
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-12 07:36:47
Reporting Period:: 2015-11-11

Filing Date:: 2015-11-12
Accepted Time:: 2015-11-12 07:36:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542052	Susan Hall	C/O Endo International Plc Minerva House, Simmonscourt Road Ballsbridge, Dublin 4 L2 00000	Evp, Cso, Global Head Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-11-11	1,000	$55.35	2,666	No	4	P	Direct
Stock Incentive Plan Performance Shares	Acquisiton	2015-11-11	1,000	$0.00	13,740	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Stock Incentive Plan Restricted Stock Units (Rsu)	7,515	Direct

Footnotes

The performance shares vest upon the Company achieving certain shareholder return targets over a cumulative 3-year period.
Represents the target number of shares issuable upon achievement of a certain shareholder return target over a cumulative 3-year period, as determined by the Registrant's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be the target number or zero, depending on the Registrant's attainment of the shareholder return target over the period.
Pursuant to the Endo International plc Matched Performance Share Unit Program, the Registrant matched Ms. Hall's open market purchases of ordinary shares, subject to certain limitations, which occurred on November 11, 2015, as reported above. These securities were granted to Ms. Hall in consideration of her services as the Executive Vice President, Chief Scientific Officer, Global Head of R&D of Endo International plc.
Represents the cumulative target quantity of shares issuable with respect to all 2010 and 2015 Stock Incentive Plan performance shares outstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 Stock Incentive Plan and the 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on the achievement of certain performance metrics as described herein for the current grant and as previously disclosed for all other performance share grants.
Subject to time-based vesting, each restricted stock automatically converts into one (1) ordinary share of Endo International plc.